Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

• NCT07800598

  Phase 4, Recruiting, 54 people, 2 Sept 2026

• NCT07773909

  Phase 4, Completed, 24 people, 19 Aug 2026

• NCT07472166

  Phase 4, Completed, 34 people, 16 Mar 2026

• NCT07428551

  Phase 4, Completed, 50 people, 23 Feb 2026

• NCT07375693

  Phase 2, Enrolling by invitation, 70 people, 29 Jan 2026

• NCT07161336

  Phase 2, Recruiting, 70 people, 8 Sept 2025

• NCT07102225

  Phase 3, Active, not recruiting, 56 people, 3 Aug 2025

• NCT07055958

  Phase 3, Active, not recruiting, 74 people, 9 Jul 2025

• NCT06936215

  Phase 3, Recruiting, 24 people, 20 Apr 2025

• Semaglutide in Women With Polycystic Ovary Syndrome and Obesity

  Phase 2/3, Completed, 31 people, 26 Mar 2025

• NCT06560814

  Phase 2, Completed, 18 people, 19 Aug 2024

• NCT06310057

  Phase 4, Completed, 92 people, 13 Mar 2024

• NCT06299670

  Phase 4, Completed, 90 people, 8 Mar 2024

• NCT06252194

  Phase 2, Status unknown, 120 people, 9 Feb 2024

• NCT06126029

  Phase 2, Status unknown, 68 people, 13 Nov 2023

• NCT06114407

  Phase 2, Status unknown, 184 people, 2 Nov 2023

• NCT06101147

  Phase 2, Completed, 66 people, 26 Oct 2023

• NCT06044844

  Phase 2, Status unknown, 44 people, 21 Sept 2023

• NCT05997524

  Phase 2, Completed, 60 people, 18 Aug 2023

• NCT05959044

  Phase 2, Status unknown, 60 people, 25 Jul 2023

Sources: clinicaltrials.gov